Advertisement

Irish Journal of Medical Science

, Volume 174, Issue 1, pp 33–36 | Cite as

Solitary plasmacytoma: experiences from Central Anatolia

  • H. S. Coskun
  • O. Er
  • S. Soyuer
  • M. Altinbas
  • B. Eser
  • E. Karahacioglu
  • F. Altuntas
Original Paper
  • 31 Downloads

Abstract

Background

Solitary plasmacytoma localised to bone or soft tissue without myeloma.

Aim

Clinical features and survival was analysed in patients from Central Anatolia.

Methods

Twenty-three solitary plasmacytoma (18 male, 5 female) were evaluated retrospectively. Median age was 58 years (46–72). The major localisation was vertebral column.

Results

All patients but one (larynx) had surgical resection and 21 patients received radiotherapy postoperatively. Multiple myeloma developed in eight patients (35%) and local relapse was detected in one patient. Eight patients died, causes of death were multiple myeloma progression in six patients, local relapse of intracranial plasmacytoma in one patient and cranial trauma in one patient who was in complete remission.Three and 5 years progression free survival were 45.6% and 22.8% respectively and overall survivals were 54.4% and 27.2% respectively.

Conclusion

Solitary plasmacytoma cases should be followed carefully regarding local relapse and progression to myeloma.

Keywords

Multiple Myeloma IRISH Journal Local Relapse Plasmacytoma Extramedullary Plasmacytoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Roberts SE, Goldacre MJ. Time trends and dem Foerster J, Paraskevas F. Multiple myeloma. In: Wintrobe’s Clinical Hematoiogy. Eds Lee GR, Foerster J, Lukens J.Williams & Wilkins, Egypt, 1999;2631–2680.Google Scholar
  2. 2.
    Galieni P, Cavo G, Avvisati G et al. Solitary plasmacytoma of bone and extramedullary plasmacytoma.Two different entities?Ann Oncol 1995;6: 687–691.PubMedGoogle Scholar
  3. 3.
    Holland J, Trenkner DA, Wasserman TH, Fineberg B. Plasmacytoma. Treatment, results and conversion to myeloma.Cancer 1992;69: 1513–1517.CrossRefPubMedGoogle Scholar
  4. 4.
    Chak LY, Cox RS, Bostwick DG, Hoppe RT. Solitary plasmacytoma of bone: Treatment, progression, and survival.J Clin Oncol 1987;5: 1811–1815.PubMedGoogle Scholar
  5. 5.
    Wax MK, Yun KJ, Omar RA. Extra medullary plasmacytomas of the head and neck.Otolaryngol Head Neck Surg 1993;109: 877–885.PubMedGoogle Scholar
  6. 6.
    Fisher C, Terpe HJ, Weidner W, Schultz A. Primary plasmacytoma of testis. Case report and review of the literature.Urol Int 1996;56: 263–265.CrossRefGoogle Scholar
  7. 7.
    Mancardi GL, Mandybur TI. Solitary intracranial plasmacytoma.Cancer 1983;51: 2226–2233.CrossRefPubMedGoogle Scholar
  8. 8.
    Oppenheim PI, Cohen S, Anders KH. Testicular plasmacytoma. A case report with immunohistochemical studies and literature review.Arch Pathol Lab Med 1991;115: 629–632.PubMedGoogle Scholar
  9. 9.
    Taylor RE, Duncan W, Parker AC. Case report: Bilateral testicular plasmacytoma.Clin Radiology 1986;37: 293–294.CrossRefGoogle Scholar
  10. 10.
    Arienta C, Caroli M, Ceretti L, Villani R. Solitary plasmacytoma of the calvarium: Two cases treated by operation alone.Neurosurg 1987;21: 260–263.CrossRefGoogle Scholar
  11. 11.
    Dimopoulos MA, Goldstein J, Fuller L, Delasalle K, Alexanian R. Curability of solitary bone plasmacytoma.J Clin Oncol 1992;10: 587–590.PubMedGoogle Scholar
  12. 12.
    Kaufman J, Lonial S. Multiple myeloma: the role of transplant and novel treatment strategies.Semin Oncol 2004;31(2 Suppl 4): 99–105.CrossRefPubMedGoogle Scholar
  13. 13.
    Soutar R, Lucraft H, Jackson G et al. Guidelines Working Group of the UK Myeloma Forum; British Committee for Standards in Haematology: British Society for Haematology. Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma.Br J Haematol 2004;124: 717–726CrossRefPubMedGoogle Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  • H. S. Coskun
    • 2
  • O. Er
    • 1
    • 2
  • S. Soyuer
    • 1
    • 2
  • M. Altinbas
    • 1
    • 2
  • B. Eser
    • 1
    • 2
  • E. Karahacioglu
    • 1
    • 2
  • F. Altuntas
    • 1
    • 2
  1. 1.Erciyes University Medical FacultyMK Dedeman Oncology HospitalKayseriTurkey
  2. 2.Medical Faculty Dept. of Internal MedicineSuleyman Demirel UniversityIspartaTurkey

Personalised recommendations